Business / Finance

RSS

TrialReach raises $13.5M in Series B financing round

TrialReach, the world's largest provider of clinical trial information, today announced it has raised a $13.5M Series B financing round led by Smedvig Capital with participation from existing investors Amadeus Capital Partners and Octopus Investments. With one of the biggest digital health rounds ever raised in the United Kingdom, TrialReach plans to use the funds to support the growth of its clinical trial platform and expansion into the U.S..

6 Feb 2015

Crown Bioscience, NRCMM partner to develop new immune-oncology experimental cancer models

Crown Bioscience, Inc., a leading global drug discovery and development service company with its R&D centers across the globe has announced that a new partnership agreement has been reached with the National Resource Center for Mutant Mice and its commercial branch Nanjing Biotech Innovation Corporation, in Nanjing, Jiangsu Province, China.

6 Feb 2015

Roper Industries signs definitive agreements to acquire Data Innovations, SoftWriters

Roper Industries, Inc. today announced that it has entered into definitive agreements to acquire two medical software companies: Data Innovations, LLC and SoftWriters, Inc.

6 Feb 2015

DWHP sells Career Step Holdings to Revelstoke

DW Healthcare Partners, a healthcare-focused private equity firm with offices in Toronto, Ontario and Park City, Utah, announced the sale of its portfolio company, Career Step Holdings, LLC to Revelstoke Capital Partners, a Denver-based private equity firm. The terms of the transaction were not disclosed.

5 Feb 2015

InDemand Interpreting awarded group purchasing contract with Premier

InDemand Interpreting, a leading provider of Video Remote Interpreting (VRI) within healthcare, has been awarded a group purchasing contract with Premier, Inc. to offer experienced medical interpreters and the highest quality video technology to Premier members.

5 Feb 2015

Isis receives $10 million from Biogen Idec to begin IND-supporting studies of ISIS-BIIB4 Rx

Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec for initiating the investigational new drug (IND)-supporting studies of ISIS-BIIB4 Rx.

5 Feb 2015

RXi closes exclusive global license agreement with Hapten Pharmaceuticals for Samcyprone

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapies addressing high-unmet medical needs, today announced the closing of its previously disclosed exclusive global license agreement for the therapeutic use of Samcyprone with Hapten Pharmaceuticals, LLC.

5 Feb 2015

USANA Health Sciences Singapore obtains CaseTrust accreditation

The USANA Health Sciences Singapore office recently had their business practices accredited by CaseTrust, the accreditation arm of the Consumers Association of Singapore (CASE). The initiative, which is led by the Direct Selling Association of Singapore, was kicked off in January 2014 with the intention to bring the standards of the direct selling industry in Singapore to a higher standard.

5 Feb 2015

Misonix net sales increase 36% to $5.6 million in second quarter fiscal 2015

Misonix, Inc., an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the second quarter of fiscal 2015, ended December 31, 2014.

5 Feb 2015

Welch Allyn partners with Nonin Medical to provide clinically-proven PureSAT SpO2 technology

Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, today announced it has partnered with Nonin Medical, a leader in designing and manufacturing noninvasive medical monitoring solutions, to provide its clinically-proven PureSAT SpO2 technology.

4 Feb 2015

PRO-DEX completes acquisition of Fineline Molds

PRO-DEX, INC. today announced that on February 1, 2015 it completed its acquisition of substantially all of the assets of Fineline Molds, a company located in San Dimas, Calif. that manufactures plastic injection molding tools.

4 Feb 2015

BioClinica reports 2014 as record year for its eClinical technologies business unit

BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced that 2014 was a record year for its eClinical technologies business unit, with sales soaring 51 percent above the previous year.

From Clario 4 Feb 2015

Edwards Lifesciences’ net sales increase 15% to $618.0M in Q4 2014

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended December 31, 2014 of $109.2 million, or $1.00 per diluted share, and non-GAAP1 net income of $116.5 million, or $1.06 per diluted share. Net income for the same period a year earlier was $75.1 million, or $0.68 per diluted share, and non-GAAP net income was $105.0 million, or $0.95 per diluted share.

4 Feb 2015

Omnicell's revenue increases 8.0% to $121.5 million in fourth quarter 2014

Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced results for its fourth quarter and year ended December 31, 2014.

From Omnicell, Inc. 4 Feb 2015

EyeBrain raises €1.3 million ($1.47 million) through crowdfunding

EyeBrain, a company that develops markers of cerebral function for neurological and psychiatric disorders and diseases, today announces the conclusion of a new round of funding. A total of €1.3 million ($1.47 million) has been raised with the support of EyeBrain’s shareholders, the Fonds Régional de Co-Investissement d’Ile-de-France (FRCI, regional joint investment fund for the Ile-de-France or Greater Paris area) and the Anaxago crowdfunding platform.

4 Feb 2015

Cphi partners with InformEx to launch new InformEx cGMP Zone at 2015 show

CPhI, the leading global sourcing event for the pharmaceutical industry, is partnering with InformEx to launch the new, InformEx cGMP Zone at the 2015 show (3-5th February in New Orleans).

4 Feb 2015

Cardinal Health approves quarterly dividend of $0.3425 per share

Cardinal Health today announced that its board of directors approved a quarterly dividend of $0.3425 per share.

4 Feb 2015

BioMed Realty Trust expands footprint in Seattle's core innovation district of South Lake Union

BioMed Realty Trust, Inc. today announced that it is under contract to acquire the 307 Westlake Avenue North building in the heart of the burgeoning South Lake Union life science market of Seattle, Washington for approximately $90 million.

4 Feb 2015

Neovasc closes underwritten public offering of common stock

Neovasc Inc. is pleased to announce the closing of its previously announced underwritten public offering of 12,075,000 common shares of the Company at a price per share of US$7.19 (the "Offering") for aggregate gross proceeds of approximately US$74,883,850 for the Company and US$11,935,400 for the Selling Securityholders (as defined below) before deducting underwriting discounts and commissions and offering expenses payable by the Company and the Selling Securityholders.

4 Feb 2015

Healthcare Realty Trust announces common stock cash dividend for Q4 2014

Healthcare Realty Trust Incorporated today announced its common stock cash dividend for the quarter ended December 31, 2014.

4 Feb 2015

Business / Finance

TrialReach raises $13.5M in Series B financing round

Crown Bioscience, NRCMM partner to develop new immune-oncology experimental cancer models

Roper Industries signs definitive agreements to acquire Data Innovations, SoftWriters

DWHP sells Career Step Holdings to Revelstoke

InDemand Interpreting awarded group purchasing contract with Premier

Isis receives $10 million from Biogen Idec to begin IND-supporting studies of ISIS-BIIB4 Rx

RXi closes exclusive global license agreement with Hapten Pharmaceuticals for Samcyprone

USANA Health Sciences Singapore obtains CaseTrust accreditation

Misonix net sales increase 36% to $5.6 million in second quarter fiscal 2015

Welch Allyn partners with Nonin Medical to provide clinically-proven PureSAT SpO2 technology

PRO-DEX completes acquisition of Fineline Molds

BioClinica reports 2014 as record year for its eClinical technologies business unit

Edwards Lifesciences’ net sales increase 15% to $618.0M in Q4 2014

Omnicell's revenue increases 8.0% to $121.5 million in fourth quarter 2014

EyeBrain raises €1.3 million ($1.47 million) through crowdfunding

Cphi partners with InformEx to launch new InformEx cGMP Zone at 2015 show

Cardinal Health approves quarterly dividend of $0.3425 per share

BioMed Realty Trust expands footprint in Seattle's core innovation district of South Lake Union

Neovasc closes underwritten public offering of common stock

Healthcare Realty Trust announces common stock cash dividend for Q4 2014

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News